About 100 reports

It is one major anti-cancers producer in China.

  • Lung Cancer
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Livzon Group
  • Zhejiang Expressway Co., Ltd.

It is one major anti-cancers producer in China.

  • Lung Cancer
  • China
  • Supply
  • Livzon Group
  • Zhejiang Expressway Co., Ltd.
  • VX-001 - DRUG PROFILE

The present invention pertains to the field of vaccination, and more particularly to the fields of antitumor and antiviral vaccination.

  • Cancer
  • Immunotherapy
  • Lung Cancer
  • Therapy
  • Geron Corporation

Antiviral effects of TG##have also been shown TG## is currently being evaluated in an international first-in-man Phase ##/ ##b trial in patients who are being treated for chronic HBV infection with standard-of-care antiviral therapies.

  • Lung Cancer
  • Pharmaceutical
  • France
  • United States
  • Transgene SA

Immune-related AEs comprised grade ## ALT elevation (n = ##), grade ## AST elevation (n = ##), grade ## pneumonitis (n = ##), and grade ## thyroid-stimulating hormone elevation (n = ##).

  • Cancer
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.

This JAK/ STAT activation mediates signal transduction and activates various immunomodulatory and antiviral proteins.

  • Blood Disease
  • Lung Cancer
  • United States
  • Product Initiative
  • Incyte Corporation
  • NIVOLUMAB - DRUG PROFILE

Recent presentations at AIDS 2012 and The International Conference on Antiviral Research have provoked federal research interest in the development of CS-TATI-##.

  • Chemotherapy
  • Lung Cancer
  • Therapy
  • United States
  • Product Initiative
  • PIPELINE BY CLOVIS ONCOLOGY INC, H2 2018

IT ACTS BY TARGETING PARP ## AND ## AND TANKYRASE ## AND ##.

  • Lung Cancer
  • Oncology
  • Targeted Therapy
  • Therapy
  • AstraZeneca PLC

The specific inhibition of multiple HPV induced pathways by sinecatechins reasonably contributes to the clearance of external genital wart, likely via direct antiviral and immunostimulatory effects.

  • Lung Cancer
  • Therapy
  • United States
  • Product Initiative
  • Merck & Co., Inc.

Day ##).

  • Digestive System Disorder
  • Lung Cancer
  • United States
  • World
  • Product Initiative

It provides preclinical pipeline such as antiviral and oncology targets, multiple oncology targets, antiviral targets, antibacterial and antifungal targets and target against pain.

  • Cancer Immunotherapy
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Ono Pharmaceutical Co., Ltd.

This JAK/ STAT activation mediates signal transduction and activates various immunomodulatory and antiviral proteins.

  • Blood Disease
  • Lung Cancer
  • United States
  • Product Initiative
  • Incyte Corporation
  • NIVOLUMAB - DRUG PROFILE

Antiviral responses in HCV- and HBV-infected patients have been observed as measured by declines in HCV RNA and quantitative HBV surface antigen.

  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

The drug candidates are developed based on Nested Chemical Library (NCL) technology and antiViral-hyperActivation limiting therapeutics.

  • Lung Cancer
  • Research And Development
  • United States
  • Company Operations
  • Product Initiative
  • PIPELINE BY CLOVIS ONCOLOGY INC, H1 2018

E-## ACTS BY TARGETING PARP ## AND ## AND TANKYRASE ## AND ##.

  • Lung Cancer
  • Oncology
  • Ovarian Cancer
  • Therapy
  • AstraZeneca PLC

The company also has discovery antiviral programs.

  • Immunotherapy
  • Lung Cancer
  • Monoclonal Antibody
  • Therapy
  • Bristol-Myers Squibb Company

Day ##).

  • Digestive System Disorder
  • Lung Cancer
  • World
  • Product Initiative
  • Conatus Pharmaceuticals Inc.
  • NIVOLUMAB - DRUG PROFILE

Antiviral responses in HCV- and HBV-infected patients have been observed as measured by declines in HCV RNA and quantitative HBV surface antigen.

  • Blood Disease
  • Cell Therapy
  • Lung Cancer
  • Therapy
  • Bristol-Myers Squibb Company
  • VX-001 - DRUG PROFILE

The present invention pertains to the field of vaccination, and more particularly to the fields of antitumor and antiviral vaccination.

  • Cancer
  • Lung Cancer
  • United States
  • World
  • Product Initiative
  • Research and Development Brief

Antiviral responses in HCV- and HBV-infected patients have been observed as measured by declines in HCV RNA and quantitative HBV surface antigen.

  • Hospital
  • Lung Cancer
  • Therapy
  • United States
  • Product Initiative

The company also has discovery antiviral programs.

  • Cancer
  • Lung Cancer
  • Therapy
  • United States
  • Product Initiative

Each Unit consists of one Common Share and one Warrant of the Corporation.

  • Lung Cancer
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative

DATA FROM THE STUDY IN SQUIRREL MONKEY SHOWED THAT CYCLOPHOSPHAMIDE DID NOT CAUSE SIGNIFICANT TOXICITY TO THE ANIMALS BUT WEAKLY SUPPRESSED THE ANTIVIRAL IMMUNE RESPONSE SUFFICIENT TO FACILITATE MORE EXTENSIVE SPREAD OF THE VIRUS BEFORE ITS ELIMINATION.

  • Hospital
  • Lung Cancer
  • Therapy
  • United States
  • Merck & Co., Inc.

Hoffmann-La Roche Ltd Partner ## Partner ## Deal status Completed DEAL IN BRIEF Deal sub-category Date of announcement Date of completion DEAL RATIONALE Licensing agreement Dec ##, 2017 Dec ##, 2017 COMPANY INFORMATION: PARTNERS PARTNER ##: F.

  • Cancer
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Ionis Pharmaceuticals, Inc.

The company' s products serve in fields of medicinal chemistry, pharmacology, oncology, cardiovascular and respiratory diseases, and antiviral treatments.

  • Hepatitis
  • Lung Cancer
  • Therapy
  • United States
  • Company Operations

Antiviral responses in HCV- and HBV-infected patients have been observed as measured by declines in HCV RNA and quantitative HBV surface antigen.

  • Blood Disease
  • Cell Therapy
  • Lung Cancer
  • Therapy
  • Bristol-Myers Squibb Company
  • CSTATI-1 - DRUG PROFILE
  • TRANSGENE SA

Recent presentations at AIDS 2012 and The International Conference on Antiviral Research have provoked federal research interest in the development of CS-TATI-##.

  • Cancer
  • Lung Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.

DAY ##).

  • Chemotherapy
  • Lung Cancer
  • United States
  • World
  • Product Initiative
  • 3. GDCT ID IS THE UNIQUE ID OF GLOBALDATA'S PHARMA INTELLIGENCE CENTER CLINICAL TRIAL DATABASE

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Lung Cancer
  • Monoclonal Antibody
  • United States
  • World